» Authors » Bokang Rabasha

Bokang Rabasha

Explore the profile of Bokang Rabasha including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 772
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Molebatsi K, Iyer H, Kohler R, Gabegwe K, Nkele I, Rabasha B, et al.
Int J Cancer . 2022 Jun; 151(10):1663-1673. PMID: 35716138
In resource-limited settings, augmenting primary care provider (PCP)-based referrals with data-derived algorithms could direct scarce resources towards those patients most likely to have a cancer diagnosis and benefit from early...
2.
Keshishian H, McDonald 3rd E, Mundt F, Melanson R, Krug K, Porter D, et al.
Mol Syst Biol . 2021 Sep; 17(9):e10156. PMID: 34569154
Reliable methods to quantify dynamic signaling changes across diverse pathways are needed to better understand the effects of disease and drug treatment in cells and tissues but are presently lacking....
3.
Li H, Ericsson M, Rabasha B, Budnik B, Chan S, Freinkman E, et al.
Cell Chem Biol . 2019 Jun; 26(9):1306-1314.e5. PMID: 31204288
The proteinaceous extracellular matrix (ECM) is vital for the survival, proliferation, migration, and differentiation of many types of cancer. However, little is known regarding metabolic pathways required for ECM secretion....
4.
Jerby-Arnon L, Shah P, Cuoco M, Rodman C, Su M, Melms J, et al.
Cell . 2018 Nov; 175(4):984-997.e24. PMID: 30388455
Immune checkpoint inhibitors (ICIs) produce durable responses in some melanoma patients, but many patients derive no clinical benefit, and the molecular underpinnings of such resistance remain elusive. Here, we leveraged...
5.
Huang F, Mosquera J, Garofalo A, Oh C, Baco M, Amin-Mansour A, et al.
Cancer Discov . 2017 May; 7(9):973-983. PMID: 28515055
African-American men have the highest incidence of and mortality from prostate cancer. Whether a biological basis exists for this disparity remains unclear. Exome sequencing ( = 102) and targeted validation...